[Use of terrilytin in treating ulcerative-necrotic lesions of the oral mucosa].
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000681:Amylases / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005664:Furazolidone / Q000627:therapeutic use; D005892:Gingivitis, Necrotizing Ulcerative / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D009824:Ointments; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D012996:Solutions
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D009824:Ointments; D000644:Quaternary Ammonium Compounds; D012996:Solutions; C004921:Ethonium; C009402:amylase, phosphates, proteases drug combinations; D005664:Furazolidone; D000681:Amylases; D010447:Peptide Hydrolases
Primenenie terrilitina pri lechenii iazvenno-nekroticheskikh porazheniĭ slizistoĭ obolochki polosti rta.